Years of life lost prematurely due to COVID-19 in Ecuador
DOI:
https://doi.org/10.47464/MetroCiencia/vol30/4/2022/35-43Keywords:
Mortality, epidemiology, COVID-19, DALYAbstract
Introduction: In March 2020, the World Health Organization declared the new disease called COVID-19 a pandemic. Until the end of 2020, approximately 1.8 million deaths have been recorded worldwide. The objective of this study is to estimate and analyze the years of life lost prematurely by COVID-19 in Ecuador. Materials and Methods: Cross-sectional descriptive observational study. It was calculated from the database of the Statistical Registry of General Deaths of the year 2020 in Ecuador, the mortality rate, both by sex and by age groups. And the Years of life lost prematurely (YLL) due to COVID-19 were estimated in that period. Results: 23.789 confirmed and unconfirmed COVID-19 deaths were recorded. Mortality rates per 1.000 inhabitants were 1,8 in men and 0,9 in women. In the end, 296.193 years of life were lost prematurely. Conclusions: COVID-19 has affected all age groups and has caused a great loss of years of healthy life in the Ecuadorian population, which has repercussions on the country's productivity and therefore on its economy.
Downloads
References
Mcintosh K. COVID-19: Epidemiology, virology, and prevention. In: UpToDate, Hirsh M (Ed), UpToDate, Waltham, MA. (Accessed on June 28, 2022.)
Organización Panamericana de la Salud. La OMS caracteriza a COVID-19 como una pandemia [Internet]. 2020. p. 1. Available from: https://www3.paho.org/hq/index.php?option=com_content&view=article&id=15756:who-characterizes-COVID-19-as-a-pandemic&Itemid=1926&lang=es
Ministerio de Salud Pública. Actualización de casos de coronavirus en Ecuador [Internet]. 2022. p. 1. Available from: https://www.salud.gob.ec/actualizacion-de-casos-de-coronavirus-en-ecuador/
Cuéllar L, Torres I, Romero-Severson E, Mahesh R, Ortega N, Pungitore S, et al. Excess deaths reveal the true spatial, temporal and demographic impact of COVID-19 on mortality in Ecuador. Int J Epidemiol. 2022;51(1):54–62.
Comité de Operaciones de Emergencia Naciona. Informe de Situación COVID-19 Ecuador No. 067 [Internet]. 2020. Available from: https://www.salud.gob.ec/informes-de-situacion-sitrep-e-infografias-COVID-19-y-boletines-epidemiologicos-desde-29-02-2020/
Dirección General de Registro Civil I y C. Reporte Especial-Defunciones-Provincias. Quito; 2020.
Instituto Nacional de Estadística y Censos (INEC). Registro Estadístico de Defunciones Generales [Internet]. Instituto Nacional de Estadística y Censos. 2021. Available from: https://www.ecuadorencifras.gob.ec/defunciones-generales/
OMS. Codificación del COVID-19 con la CIE-10. Organ Mund la Salud [Internet]. 2020;1–3. Available from: https://www.paho.org/arg/index.php?option=com_docman&view=download&alias=468-covid-cie-codigos-2020-03-25-espanol&category_slug=documentos&Itemid=624
Comité de Ética de Investigación en Seres Humanos CEISH-UDLA. Proyectos sometidos al Comité de Ética de Investigación en Seres Humanos [Internet]. 2021. p. 1. Available from: https://proyectosinvestigacion.udla.edu.ec/index.php/ceish-udla
Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9.
Torres I, Sacoto F. Localising an asset-based COVID-19 response in Ecuador. Lancet [Internet]. 2020;395(10233):1339.
Barbosa P, Moreira MF, Henrique P, Bermejo DS. Mortality and Years of Potential Life Lost Due to COVID-19 in Brazil. Int. J. Environ. Res. Public Health. 2021; 18(14):7626.
Fantin R, Brenes-Camacho G, Barboza-Solís C. COVID-19 deaths: Distribution by age and universal medical coverage in 22 countries. Rev Panam Salud Publica/Pan Am J Public Heal. 2021;45:1–9.
Valdez Huarcaya W, Miranda Monzón JA, Napanga Saldaña EO, Driver CR. Impacto de la COVID-19 en la mortalidad en Perú mediante la triangulación de múltiples fuentes de datos. Rev Panam Salud Pública. 2022;46:1.
Organización Panamericana de la Salud. Reporte situación COVID-19 Colombia SITREP 202 [Internet]. 2020. Available from: https://www.paho.org/es/documentos/reporte-situacion-COVID-19-colombia-no-202-29-diciembre-2020
Our World in Data. Israel: Coronavirus Pandemic Country Profile [Internet]. 2022. Available from: https://ourworldindata.org/coronavirus/country/israel#the-case-fatality-rate
DynaMed. COVID-19 (Novel Coronavirus). EBSCO Information Services. Consultado el 23 de Noviembre del 2022. https://www.dynamed.com/condition/COVID-19-novel-coronavirus#GUID-948C30B0-A1E1-4FFE-893D-A3D64AAC9B93
World Health Organization. Ebola virus disease [Internet]. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease
Ministerio de Salud Pública. Influenza, Ecuador SE. 20 [Internet]. Weekly Epidemiological Record. 2017. Available from: https://www.salud.gob.ec/wp-content/uploads/downloads/2017/06/Boletin-Influenza-SE-20.pdf
Centers for Disease Control and Prevention. Pneumococcal Disease [Internet]. 2022. Available from: https://www.cdc.gov/pneumococcal/clinicians/streptococcus-pneumoniae.html
Organización Mundial de la Salud. 14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021 [Internet]. 2022. p. 2. Available from: https://www.who.int/news/item/05-05-2022-14.9-million-excess-deaths-were-associated-with-the-COVID-19-pandemic-in-2020-and-2021
Nguyen NT, Chinn J, De Ferrante M, Kirby KA, Hohmann SF, Amin A. Male gender is a predictor of higher mortality in hospitalized adults with COVID-19. PLoS One. 2021 Jul 9;16(7):e0254066.
Sodeifian F, Nikfarjam M, Kian N, Mohamed K, Rezaei N. The role of type I interferon in the treatment of COVID-19. J Med Virol. 2022;94(1):63–81.
Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021 Jan;27(1):28-33.
Berghöfer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H. TLR7 Ligands Induce Higher IFN-α Production in Females. J Immunol. 2006;177(4):2088–96.
Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Heal. 2020;8(April):1–6.
Mukherjee S, Pahan K. Is COVID-19 Gender-sensitive? 2021;38–47.
Bienvenu LA, Noonan J, Peter K, Wang X. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. 2020;1–10.
Danielsen AC, Lee KM, Boulicault M, Rushovich T, Gompers A, Tarrant A, Reiches M, Shattuck-Heidorn H, Miratrix LW, Richardson SS. Sex disparities in COVID-19 outcomes in the United States: Quantifying and contextualizing variation. Soc Sci Med. 2022 Feb;294:114716.
Grupo Banco Mundial. Prevalencia del hábito de fumar [Internet]. 2022. p. 1. Available from: https://datos.bancomundial.org/indicator/SH.PRV.SMOK.FE?locations=EC
Kalkhoran SM, Levy DE, Rigotti NA. Smoking and E-Cigarette Use Among U.S. Adults During the COVID-19 Pandemic. Am J Prev Med. 2022 Mar;62(3):341-349.
Chen Y-J, Jian W-H, Liang Z-Y, Guan W-J, Liang W-H, Chen R-C, et al. Earlier diagnosis improves COVID-19 prognosis: a nationwide retrospective cohort analysis. Ann Transl Med. 2021;9(11):941–941.
Pifarré I Arolas H, Acosta E, López-Casasnovas G, Lo A, Nicodemo C, Riffe T, Myrskylä M. Years of life lost to COVID-19 in 81 countries. Sci Rep. 2021 Feb 18;11(1):3504.
Ferenci T. Different approaches to quantify years of life lost from COVID-19. Eur J Epidemiol. 2021 Jun;36(6):589-597.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Kevin Ricardo Espinosa Yépez
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
